Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition

Future Oncology

Volumn 11, Issue 5, 2015, Pages 771-783

  Hu, Pingping ^a   Wang, Guanghui ^a   Shen, Meixiao ^a   Zhang, Ping ^a   Zhang, Jihong ^a   Du, Jiajun ^a   Liu, Qi ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

epithelial mesenchymal transition; esophageal cancer; polymorphonuclear granulocytes; prognosis

Indexed keywords

FLUOROURACIL; GELATINASE A; GELATINASE B; UVOMORULIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CELL MIGRATION; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; ERYTHROCYTE COUNT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE COUNT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; TUMOR INVASION; AGED; CELL MOTION; CELL PROLIFERATION; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHIL INFILTRATION; PROGNOSIS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84924806314     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.306     Document Type: Article

References (25)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646-674 (2011).
2. Brandau S. The dichotomy of neutrophil granulocytes in cancer. Semin. Cancer Biol. 23(3), 139-140 (2013).
3. Shoenfeld Y, Tal A, Berliner S, Pinkhas J. Leukocytosis in non hematological malignancies - a possible tumor-associated marker. J. Cancer Res. Clin. Oncol. 111(1), 54-58 (1986).
4. Amatangelo MD, Stearns ME. Reactivation of epithelial-mesenchymal transition in invasive and metastatic cancer. In: Signaling Pathways and Molecular Mediators in Metastasis. Fatatis A (Ed.). Springer, Dordrecht, The Netherlands, 13-69 (2012).
5. Fuxe J, Karlsson MC. TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin. Cancer Biol. 22(5-6), 455-461 (2012).
6. Trellakis S, Bruderek K, Dumitru CA et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 129(9), 2183-2193 (2011).
7. Grosse-Steffen T, Giese T, Giese N et al. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. Clin. Dev. Immunol. 2012, 720768 (2012).
8. Gaida MM, Steffen TG, Gunther F et al. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors. Eur. J. Immunol. 42(12), 3369-3380 (2012).
9. Hu P, Wang G, Cao H, Ma H, Sui P, Du J. Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection. Br. J. Cancer 109(6), 1609-1617 (2013).
10. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8(3), 138-140 (1987).
11. Katsuno Y, Lamouille S, Derynck R. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 25(1), 76-84 (2013).
12. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15(3), 178-196 (2014).
13. Morrison CD, Parvani JG, Schiemann WP. The relevance of the TGF-beta Paradox to EMT-MET programs. Cancer Lett. 341(1), 30-40 (2013).
14. Borregaard N. Neutrophils, from marrow to microbes. Immunity 33(5), 657-670 (2010).
15. Piccard H, Muschel RJ, Opdenakker G. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit. Rev. Oncol. Hematol. 82(3), 296-309 (2012).
16. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103(3), 481-490 (2000).
17. Masson V, De La Ballina LR, Munaut C et al. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J. 19(2), 234-236 (2005).
18. Shen M, Hu P, Donskov F, Wang G, Liu Q, Du J. Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PloS ONE 9(6), e98259 (2014).
19. Hattar K, Franz K, Ludwig M et al. Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis. Cancer Immunol. Immunother. 63(12), 1297-1306 (2014).
20. Tazzyman S, Barry ST, Ashton S et al. Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth. Int. J. Cancer 129(4), 847-858 (2011).
21. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112(12), 1776-1784 (2003).
22. Wu Y, Zhao Q, Peng C, Sun L, Li XF, Kuang DM. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J. Pathol. 225(3), 438-447 (2011).
23. Ma GF, Miao Q, Zeng XQ et al. Transforming growth factor-beta1 and -beta2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro. PloS ONE 8(1), e54249 (2013).
24. Nowak M, Klink M, Glowacka E et al. Production of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cells. Scand J. Immunol. 71(2), 91-98 (2010).
25. Bessler H, Djaldetti M. Role of the equilibrium between colon cancer and mononuclear cells in cytokine production. Biomed. Pharmacother. 64(10), 706-711 (2010).